Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

QMSI is a valuable method for studying drug penetration in skin tissues.

Targeting ornithine decarboxylase can help prevent skin cancer.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

A rare type of skin cancer on the scalp can be mistaken for hair loss, causing delayed diagnosis and severe damage.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

PEGL-DOX causes Hand-Foot Syndrome due to skin reactions from prolonged circulation and ROS generation.

Mushroom beta-glucans from Ganoderma lucidum can reduce tumor size and metastasis in cancer.

Adding a second method to PROTACs could improve cancer treatment.

Human hair-derived particles can effectively carry and release the cancer drug Paclitaxel in a pH-sensitive manner, potentially targeting cancer cells while sparing healthy ones.

Cells with active Wnt signaling are less likely to turn into cancer when exposed to a cancer-causing gene.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

The new finasteride delivery system using chitosan-based nanoniosomes shows promise for prostate cancer prevention.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

MCPIP1 in myeloid cells is important for skin cancer development and healthy hair growth.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Researchers improved a method to study individual cells in newborn mouse skin and found a way to assess the severity of a skin condition in humans.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Platelet-rich plasma (PRP) shows promise in skin and hair treatments but results vary with preparation methods.

Dermoscopy can help assess the severity of chronic radiation-induced skin damage in head and neck cancer patients.

Diagnosing mycosis fungoides, a rare skin cancer, is difficult in elderly adults and requires careful examination to avoid mistaking it for less serious skin conditions.

Two-photon microscopy helps observe hair follicle stem cell behaviors in mice.

Polyamines help fix DNA damage accurately in cells.